Abstract-Scopolamine-induced
Anticholinergic drugs produce very little effects on the central nervous system (CNS) in man with usual therapeutic dosage, while symptoms which are ascribed to central effects, such as drowsiness, restlessness, excitation, muscular incoordination and hallucination, are observed with increasing the dose of anticholinergic drugs (1) . Anticholinergic agents, such as scopolamine and atropine, were reported to increase locomotor activity, orientational hypermotility and exploratory activity in open-field in mice and rats (2, 3, 4, 5, 6) . These excitatory effects of anticholinergics have been investigated in connection with changes in brain acetylcholine (ACh) contents or the release of ACh from cerebral cortex in small animals (7, 8, 9) .
We have found that scopolamine-induced locomotor activation was reduced by the pretreatment with a-methyl-p-tyrosine (a-MPT) or antipsychotic drugs. To determine whether or not brain catecholamine (CA) plays a role in the scopolamine-induced response,
we tested various drugs with specific or nonspecific actions on CA for their ability to modify the locomotor activation induced by scopolamine as well as apomorphine and methamphe tamine. We also studied the rotational behaviour following administration of scopolamine to mice with unilateral striatal 6-hydroxydopamine (6-OHDA) lesions, since rotational behaviour in animals with unilateral lesions in nigro-striatal dopaminergic pathway has been reported to be a sensitive model for dopaminergic stimulating agents (10, 11).
MATERIALS AND METHODS
Adult male albino mice (ddY strain) weighing between 20 and 30 g housed under uniform humidity, temperature, feeding and lighting conditions (on 0700, off 1900), were used in all experiments.
Measurement of locomotor activity
Locomotor activity was measured in the activity cage equipped with 2 light sources and opposite to them, 2 photoelectric cells 1 cm above a floor. The dimensions of the plastic cage were 30 x 20 x 13 cm. The interruptions of the light beams were registered on a counter.
Only one animal at a time was placed in the cage. All experiments were performed between 0900 and 1800. After 20 min for adaptation to the activity cage, locomotor activity was measured for at least one hour following the administration of a drug.
Injection of 6-OHDA into the unilateral striatum Locomotor activity counts following apomorphine (above) and methamphet amine (below). Activity at each time and total counts are the same as in Fig. 1 . (Fig. 2) . In the following experiments the responses to scopolamine 10 mg/kg, apomorphine 2.5 mg/kg and methamphetamine 2.5 mg/kg were examined after the pretreat ment with monoamine synthesis inhibitors and antagonists.
Eft'cts of various drugs on locomotor activation responses induced by scopolandne, apomorphine and I11etliamplletanune
The responses to scopolamine and methamphetamine were reduced after the treatment with a-MPT 100 mg/kg, i.p., three times at 24, 16 and 3 hr before the drugs, while the effect of apomorphine was not modified. The treatment with PCPA 300 mg/kg, i.p., slightly increased the locomotor activation responses to apomorphine and methamphetamine, but did not affect the response to scopolamine.
The a-adrenergic blocking agent phenoxybenzamine 10 mg,/kg, s.c., impaired the responses to scopolamine and methamphetamine, but not to apomorphine. The ;3-adrenergic blocking agent propranolol 10 mg/kg, s.c., did not affect the responses to the three agonists, i.e. scopolamine, apomorphine and methamphetamine.
Haloperidol 0.2 mg/kg, s.c., which blocks both noradrenergic and dopaminergic receptors in the CNS (13), suppressed the responses to three agonists. When pimozide, which has only a dopaminergic receptor blocking effect (13), was given at the dose of 0.2 mg/ I kg, s.c., one hour before the three agonists, it prevented the responses to apomorphine and methamphetamine.
The activation response to scopolamine was reduced by pimozide 0.4 mg/kg, s.c. These results are summarized in Table 1 as changes in the total counts for one hour after administration of the three agonists. Rotational behaviour in mice following apomorphine, methamphetamine and scopolamine Mice were given apomorphine 1.25 mg/kg, i.p., 10 days after the injection of 6-OHDA into the right striatum. Different doses of apomorphine, scopolamine or methamphetamine were given to the mice that had showed marked rotational behaviour after apomorphine 1.25 mg/kg. As shown in Fig. 3 , apomorphine 0.625, 1.25 and 2.5 mg/kg induced con tralateral rotation, which appeared in 2-3 nlin after the injection and disappeared within one hour, in a dose-dependent manner with respect to total rotation for one hour. Me thamphetamine 2.5 and 5 mg/kg, i.p., caused an ipsilateral rotation, which reached a maximum at 30 to 40 min after the injection and lasted over 2 hr. Total rotation for 2 hr was also shown in Fig. 3 . As shown in Fig. 4 , scopolamine 2.5 and 5 mg/kg produced an ipsilateral rotation, which was maximum at 10 min and thereafter decreased rapidly. Total rotation by scopolamine was less than that of methamphetamine. tically in a number of animal species. Both atropine and scopolamine exerted similar central effects, i.e. excitation and depression, in dogs. On the other hand, the increase in locomotor activity and the exploratory hypermotility in mice and rats were produced by scopolamine and atropine (2) (3) (4) (5) (6) . In the present study scopolamine produced locomotor activation, while scopolamine methylbromide did not induce the response as the quarternary salt of scopolamine was less permeable to the CNS. Both apomorphine and methamphetamine produced an increase in locomotor activity at the low doses, while they produced the stereo typed behaviour, i.e. sniffing, gnawing and licking, at the high doses. These results coincided Taken together with above results, these findings strongly suggest that scopolamine-induced locomotor activation may be mediated by brain CA.
The excitation and the increase in locomotor activity following amphetamine were prevented by a-MPT in mice (14, 16). Amphetamine-induced locomotor activation has been reported to be antagonized by phenoxybenzamine 25 mg/kg (18). These results suggested the participation of brain CA in the motor excitation with the agent (15, 19).
Apomorphine-induced stereotypy in rats was not suppressed by the pretreatment with a-MPT (20), and such was explained by the suggestion that apomorphine induced the response by the direct stimulation of dopamine receptors (20, 21).
In the rotational behaviour model of rats with unilateral degeneration of the nigro striatal dopamine system by intracerebral injection of 6-OHDA, the direction of the rotation has been found to reflect the degree of dopamine receptor stimulation in the denervated or innervated striatum (22). In the present study, scopolamine produced an ipsilateral rotation as did methamphetamine in the model of mice with 6-OHDA-induced lesions in the unilateral striatum. Amphetamine as well as methamphetamine produced an ipsilateral rotation due to the release of dopamine from the presynaptic site in the normal side of the striatum (23).
Apomorphine produced the contralateral rotation due to denervation supersensitivity to the dopamine receptor stimulation in the denervated striatum in mice as well as rats (11, Neurochemical evidence presented by previous workers indicated the release of ACh (9) but not of dopamine following anticholinergic agents, and these agents were reported to have an inhibitory effect on dopamine metabolism (24-26). On the other hand, Anden and
Bedard found both the rate of disappearance of brain noradrenaline after a-MPT and the haloperidol-induced acceleration of noradrenaline utilization to be increased after scopol amine (26). The results seem to favour the noradrenergic but not dopaminergic participation in the locomotor activation effect of scopolamine. In conclusion, we found that the scopolamine-induced locomotor activation is probably mediated by brain CA. Dopamine participation in the striatum was evidenced with application of the mouse rotational model used herein. The participation of brain CA may be related to the anticholinergic action of scopolamine.
